TipRanks
Vertex Pharmaceuticals (IT:1VRTX)
:1VRTX

Compare Vertex Pharmaceuticals (1VRTX) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
€471.90
€112.39B
29.49
35.26%
21 Buy
4 Hold
1 Sell
Strong Buy
Alnylam Pharma
$240.08
$32.06B
40.05
-46.13%
19 Buy
3 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$12.38B
168.58
17.84%
17 Buy
5 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$2.12B
-13.99
15.55%
4 Buy
8 Hold
4 Sell
Hold
Intellia Therapeutics
$13.51
$1.70B
-3.64
-21.62%
6 Buy
4 Hold
2 Sell
Moderate Buy
Crispr Therapeutics AG
$60.90
$5.47B
-12.25
-6.40%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IT:1VRTX
Vertex Pharmaceuticals
444.40
118.50
36.36%
ALNY
Alnylam Pharma
244.32
-214.60
-46.76%
BMRN
BioMarin Pharmaceutical
64.06
10.12
18.76%
SRPT
Sarepta Therapeutics
20.14
1.49
7.99%
NTLA
Intellia Therapeutics
12.22
-5.04
-29.20%
CRSP
Crispr Therapeutics AG
58.33
-3.77
-6.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts